NCT06756633 Respiratory Functions, Thoracoabdominal Movements and Exercise Capacity in Neuromuscular Diseases
| NCT ID | NCT06756633 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Lokman Hekim University |
| Condition | Neuromuscular Diseases in Children |
| Study Type | OBSERVATIONAL |
| Enrollment | 42 participants |
| Start Date | 2024-04-01 |
| Primary Completion | 2025-12-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 42 participants in total. It began in 2024-04-01 with a primary completion date of 2025-12-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The clinical trial titled "Investigation of Respiratory Functions, Thoracoabdominal Movements, and Exercise Capacity in Neuromuscular Diseases" aims to evaluate the respiratory functions, thoracoabdominal movements, and exercise capacity in children with Duchenne Muscular Dystrophy (DMD) and Spinal Muscular Atrophy (SMA) compared to healthy controls. The study will use spirometry, structured light plethysmography (SLP), the six-minute walk test, and the six-minute pegboard ring test to assess these functions. This trial will be conducted at the Lokman Hekim University Muscle and Nerve Diseases Application and Research Center from May 2024 to Dec 2025.
Eligibility Criteria
1. Duchenne Muscular Dystrophy (DMD) -Inclusion Criteria: Clinically diagnosed with Duchenne Muscular Dystrophy. Age above 5 years. Able to breathe independently. Willing to participate in the study. -Exclusion Criteria: Presence of cognitive problems that affect the assessment results. History of pulmonary surgery. Advanced heart failure. 2. Spinal Muscular Atrophy (SMA) -Inclusion Criteria: Clinically diagnosed with Spinal Muscular Atrophy. Age above 5 years. Able to breathe independently. Willing to participate in the study. -Exclusion Criteria: Presence of cognitive problems that affect the assessment results. History of pulmonary surgery. Advanced heart failure. 3. Healthy Controls * Inclusion Criteria: No diagnosis of neuromuscular diseases. Age above 5 years. Able to breathe independently. Willing to participate in the study. -Exclusion Criteria: Presence of cognitive problems that affect the assessment results. History of pulmonary surgery. Advanced heart failure.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06756633 clinical trial?
This trial is open to participants of all sexes, aged 5 Years or older, up to 15 Years, studying Neuromuscular Diseases in Children. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06756633 currently recruiting?
Yes, NCT06756633 is actively recruiting participants. Contact the research team at taskinbilge@gmail.com for enrollment information.
Where is the NCT06756633 trial being conducted?
This trial is being conducted at Ankara, Turkey (Türkiye).
Who is sponsoring the NCT06756633 clinical trial?
NCT06756633 is sponsored by Lokman Hekim University. The trial plans to enroll 42 participants.